| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $98,784 | 1 | 100 |
Sells | $0 | 0 | 0 |
| KROLL MARK W | director | 1 | $98,784 | 0 | $0 | $98,784 |
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, …
Over the last 12 months, insiders at Haemonetics Corporation have bought $98,784 and sold $0 worth of Haemonetics Corporation stock.
On average, over the past 5 years, insiders at Haemonetics Corporation have bought $98,784 and sold $3.54M worth of stock each year.
Highest buying activity among insiders over the last 12 months: KROLL MARK W (director) — $98,784.
The last purchase of 1,400 shares for transaction amount of $98,784 was made by KROLL MARK W (director) on 2025‑11‑10.
| 2025-11-10 | KROLL MARK W | director | 1,400 0.003% | $70.56 | $98,784 | +7.78% | ||
| 2024-07-26 | Sale | Strong Stewart W | President, Global Hospital | 4,312 0.0085% | $91.15 | $393,039 | -18.80% | |
| 2024-07-12 | Sale | Lingamneni Anila | EVP, Chief Technology Officer | 79 0.0002% | $90.00 | $7,110 | -18.01% | |
| 2024-07-11 | Sale | Lingamneni Anila | EVP, Chief Technology Officer | 2,136 0.0045% | $90.00 | $192,240 | -16.92% | |
| 2024-05-29 | Sale | Basil Michelle L | EVP and General Counsel | 12,990 0.0257% | $88.08 | $1.14M | -13.85% | |
| 2024-05-29 | Sale | Strong Stewart W | President, Global Hospital | 8,857 0.0174% | $87.53 | $775,253 | -13.85% | |
| 2024-05-20 | Sale | Basil Michelle L | EVP and General Counsel | 1,604 0.0032% | $95.08 | $152,508 | -20.68% | |
| 2024-05-20 | Sale | Llorens Josep | EVP, Global Manufacturing | 987 0.0019% | $95.08 | $93,844 | -20.68% | |
| 2024-05-20 | Sale | Strong Stewart W | President, Global Hospital | 686 0.0013% | $95.11 | $65,245 | -20.68% | |
| 2024-05-17 | Sale | Basil Michelle L | EVP and General Counsel | 1,073 0.0021% | $95.00 | $101,935 | -21.05% | |
| 2024-05-17 | Sale | Llorens Josep | EVP, Global Manufacturing | 822 0.0016% | $94.82 | $77,942 | -21.05% | |
| 2024-05-16 | Sale | Basil Michelle L | EVP and General Counsel | 985 0.002% | $96.14 | $94,698 | -20.26% | |
| 2024-05-16 | Sale | Llorens Josep | EVP, Global Manufacturing | 770 0.0015% | $96.14 | $74,028 | -20.26% | |
| 2024-05-16 | Sale | Strong Stewart W | President, Global Hospital | 733 0.0015% | $96.04 | $70,397 | -20.26% | |
| 2024-05-06 | Sale | Lingamneni Anila | EVP, Chief Technology Officer | 2,305 0.0045% | $95.00 | $218,975 | -19.99% | |
| 2023-09-12 | Sale | Strong Stewart W | President, Global Hospital | 228 0.0005% | $90.65 | $20,668 | -5.54% | |
| 2023-09-11 | Sale | Lingamneni Anila | EVP, Chief Technology Officer | 2,305 0.0045% | $90.00 | $207,450 | -6.30% | |
| 2023-09-05 | Sale | Dockendorff Charles J | director | 10,215 0.0202% | $87.68 | $895,651 | -2.36% | |
| 2023-07-18 | Sale | Llorens Josep | EVP, Global Manufacturing | 4,928 0.0095% | $90.00 | $443,520 | -6.20% | |
| 2023-06-07 | Sale | Strong Stewart W | President, Global Hospital | 2,538 0.005% | $88.04 | $223,446 | -2.39% |
| KROLL MARK W | director | 24757 0.0544% | $2.98M | 1 | 10 | |
| Simon, Christopher | President & CEO | 213724 0.4698% | $25.71M | 1 | 21 | +13.41% |
| CONCANNON BRIAN | President & CEO | 147040 0.3232% | $17.69M | 8 | 57 | +8.69% |
| GELBMAN RONALD G | director | 48384 0.1063% | $5.82M | 1 | 16 | +4.67% |
| LINDOP CHRISTOPHER J | CFO & EVP Business Development | 45350 0.0997% | $5.45M | 12 | 15 | +4.66% |
| ALLEN PETER M | President, Global Plasma | 34102 0.075% | $4.1M | 20 | 22 | +7.23% |
| White Jonathan | Chief Science and Technology | 30507 0.0671% | $3.67M | 7 | 5 | +3.73% |
| FOOTE SUSAN BARTLETT | director | 20740 0.0456% | $2.49M | 1 | 9 | <0.0001% |
| HANLON SUSAN M | VP Finance | 20464 0.045% | $2.46M | 18 | 20 | +5.11% |
| Jesse Sandra | EVP and Chief Legal Officer | 20096 0.0442% | $2.42M | 3 | 2 | +5.46% |
| MERRIMAN RONALD | director | 17807 0.0391% | $2.14M | 1 | 9 | <0.0001% |
| FORISH JOSEPH J | VP, Human Resources | 17279 0.038% | $2.08M | 9 | 10 | +4.98% |
| EBBELING ROBERT B | Vice President, Operations | 15849 0.0348% | $1.91M | 9 | 4 | +6.35% |
| GRANADILLO PEDRO P | director | 15335 0.0337% | $1.84M | 4 | 13 | +2.48% |
| Granville William | VP, Manufacturing | 12188 0.0268% | $1.47M | 1 | 0 | +4.75% |
| ABERNATHY ROBERT E | director | 12048 0.0265% | $1.45M | 1 | 0 | +18.77% |
| LOPEZ ALICIA R | VP, Corporate Affairs | 11017 0.0242% | $1.33M | 13 | 24 | +4.9% |
| BEST LAWRENCE C | director | 10001 0.022% | $1.2M | 1 | 7 | +0.57% |
| NUTTER BRAD | Chairman of the Board | 9387 0.0206% | $1.13M | 1 | 11 | +26.67% |
| Helsel Dave | EVP, Global Manufacturing | 6856 0.0151% | $824,639.68 | 2 | 0 | +2.96% |
| Popovsky Mark A | VP, Corporate Medical Director | 4891 0.0108% | $588,289.48 | 7 | 5 | +4.13% |
| Gordon Mikael | President, Global Markets | 4442 0.0098% | $534,283.76 | 3 | 5 | +6.2% |
| Still William Roche | VP & Gen Mrg, Therapeutics Bus | 4193 0.0092% | $504,334.04 | 6 | 2 | +1.45% |
| O'Shaughnessy James | 3781 0.0083% | $454,778.68 | 1 | 0 | +4.75% | |
| Brancazio Phillip John | VP, Global Manufacturing | 3052 0.0067% | $367,094.56 | 3 | 0 | +0.64% |
| SWENSON STEPHEN | VP & General Mgr, Global Plasm | 3024 0.0066% | $363,726.72 | 1 | 2 | +4.75% |
| Pare Anthony | 2523 0.0055% | $303,466.44 | 1 | 2 | +4.75% | |
| SAKURADA YUTAKA | President, Japan & Asia | 2347 0.0052% | $282,297.16 | 2 | 0 | +16.87% |
| RYAN RONALD J | VP and CFO | 2101 0.0046% | $252,708.28 | 5 | 4 | +5.1% |
| BEUCLER MARK | 1989 0.0044% | $239,236.92 | 1 | 0 | +4.75% | |
| Conneely Jan | VP & GM, Arryx, Inc. | 1041 0.0023% | $125,211.48 | 1 | 0 | +4.75% |
| ECKERT ULRICH | President, Europe & Latin Am | 890 0.002% | $107,049.20 | 2 | 4 | +2.88% |
| Hattori Keiko | President, Haemonetics Japan | 716 0.0016% | $86,120.48 | 1 | 0 | +4.75% |
| RUXIN MICHAEL I | VP Global Software Strategies | 215 0.0005% | $25,860.20 | 1 | 0 | +6.76% |
| Increased Positions | 173 | +44.82% | 10M | +18.6% |
| Decreased Positions | 179 | -46.37% | 11M | -20.43% |
| New Positions | 78 | New | 881,072 | New |
| Sold Out Positions | 44 | Sold Out | 3M | Sold Out |
| Total Postitions | 380 | -1.55% | 51M | -1.83% |
| Blackrock, Inc. | $481,534.00 | 12.81% | 6.02M | -344,100 | -5.41% | 2025-09-30 |
| Vanguard Group Inc | $386,675.00 | 10.29% | 4.83M | -118,686 | -2.4% | 2025-09-30 |
| Neuberger Berman Group Llc | $293,549.00 | 7.81% | 3.67M | -607,171 | -14.2% | 2025-09-30 |
| Aqr Capital Management Llc | $170,268.00 | 4.53% | 2.13M | +2M | +372.82% | 2025-09-30 |
| State Street Corp | $144,022.00 | 3.83% | 1.8M | -83,254 | -4.42% | 2025-09-30 |
| River Road Asset Management, Llc | $132,350.00 | 3.52% | 1.65M | -886 | -0.05% | 2025-09-30 |
| Ubs Group Ag | $116,177.00 | 3.09% | 1.45M | +582,782 | +67% | 2025-09-30 |
| Royal Bank Of Canada | $100,840.00 | 2.68% | 1.26M | +169,285 | +15.51% | 2025-09-30 |
| Fmr Llc | $97,242.00 | 2.59% | 1.22M | +379,982 | +45.46% | 2025-09-30 |
| Geode Capital Management, Llc | $96,246.00 | 2.56% | 1.2M | -41,244 | -3.31% | 2025-09-30 |